MedPath

A Patient Navigation Program to Increase Access to Early Supportive Care in Patients With Stage IV Solid Tumors

Not Applicable
Completed
Conditions
Neoplasm Metastasis
Interventions
Other: Patient Navigation
Registration Number
NCT03293849
Lead Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Brief Summary

In this randomized clinical trial, patients with Stage IV solid tumors will be enrolled in a patient navigator-led generalist palliative and supportive care intervention or in usual care led by their treating physician. The patient navigator will assess the patient's palliative and supportive care needs using standardized quality of life and symptoms questionnaires and present this assessment to a multidisciplinary team composed of oncologists and palliative care specialist. The multidisciplinary team will develop a personalized supportive care plan for the patient which will then be presented and discussed by the patient navigator. Those interventions which are accepted by the patient will be implemented by the patient navigator, who will also provide education and teaching. The patient navigator will also help eligible patients complete advanced directives according to local rules and regulations. The patient navigator will follow the patients both in person and by telephone to ensure that the recommended interventions have been implemented. Three months after enrollment the patients will undergo quality of life and symptom assessment once again, and the implementation of interventions will be recorded.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
134
Inclusion Criteria
  1. Male or female patients 18 years of age and older
  2. Newly diagnosed stage IV solid tumor
  3. Recurrent stage IV solid tumor
Exclusion Criteria
  1. Homeless persons
  2. History of drug abuse or alcoholism
  3. Patients suffering from major psychotic disorders or uncontrolled psychiatric disorders
  4. Mentally disabled patients
  5. Incarcerated patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Patient Navigation ArmPatient NavigationAfter an assessment of supportive care needs, a patient navigator will present assessment results and develop and implement a personalized supportive care intervention plan based on the findings in collaboration with a multidisciplinary supportive care team, formed by oncologists and pain and palliative care specialists. The developed plan will be sent to the treating oncologist and oncology team.
Primary Outcome Measures
NameTimeMethod
Referrals to Supportive Care ServicesThree months

Proportion of patients who agree to participate in the patient navigation program, complete the initial assessment, meet with the patient navigator to discuss advanced care planning and supportive care interventions and obtain the appropriate referrals and consultations.

Secondary Outcome Measures
NameTimeMethod
Changes in self-reported painThree months

Changes in self reported pain measured using the BPI scale from baseline.

Use of chemotherapy at the end of life18 months

Interval between last administration of chemotherapy and death

Healthcare utilization18 months

Sum of hospital admissions, emergency room admissions and ICU admissions during the study period

Rate of advanced directive completionThree months

Obtaining a signed advanced directive

Survival18 months

Overall survival (defined as time from study enrollment to last recorded visit or death)

Implementation of planned supportive care interventionsThree months

Documentation of the planned interventions on the patient's medical record at end-of-study

Changes in QOLThree months

Changes in QOL measured using the FACT-G from baseline.

Trial Locations

Locations (1)

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

🇲🇽

Mexico City, Mexico

© Copyright 2025. All Rights Reserved by MedPath